Drug Discovery · Biotechnology
Sail Biomedicines news and milestones
Sail Biomedicines: 20 headlines on record, 2 headlines in the last 90 days. Its story counts 3 milestones.
Data updated Nov 17, 2026 · Back to the company report
20Headlines
2In 90 days
3Milestones
Headlines
Sep 292026
News · pharmexec.com
Vincent Hennemand discusses using these types of therapies to develop treatments for autoimmune conditions.
Sep 292026
News · pharmexec.com
Johnson & Johnson moves to acquire Sail Biomedicines, Processa acquires Vidya Therapeutics, and Relation partners with GSK on AI-driven target discovery collaboration.
Aug 22026
News · Pulse 2.0
Johnson & Johnson has entered into strategic agreements with Sail Biomedicines to develop in vivo CAR-T therapies for immune-mediated diseases and has secured an exclusive option…
Jul 312026
News · pharmabiz.com
J&J collaborates with Sail Biomedicines to advance in vivo CAR-T programmes and transform autoimmune disease via immune reset
Jul 302026
News · YahooFinance
CAMBRIDGE, Mass., July 29, 2026--Sail Biomedicines Announces Strategic Collaboration to Develop New Class of Medicines for In Vivo CAR-T
Apr 272026
News · YahooFinance
CAMBRIDGE, Mass., April 27, 2026--Sail to Present Preclinical Data Supporting Advancement of Its In Vivo eRNA CAR-T Product Candidate to the Clinic at ASGCT 2026 and TIDES USA 2026
Mar 242026
News · drugdiscoverynews.com
Dec 12, 20252025
News · Drug Target Review
RNA therapies are moving past burst-and-fade limits. New advances in circular RNA and targeted delivery could transform how we treat autoimmune disease, infections and beyond.
Nov 4, 20252025
News · technologynetworks.com
Jun 2, 20252025
Press release · businesswire.com
May 30, 20252025
News · advancingrna.com
The closed-loop structure of circular RNA can offer sustained, durable expression. We caught up with Sail Biomedicines Kerry Benenato and Rajesh Ramaswamy to chat about ways to l…
May 13, 20252025
May 13, 20252025
Apr 30, 20252025
News · European Pharmaceutical Manufacturer
Sail Biomedicines' Kerry Benenato and Rajesh Ramaswamy discuss the roles artificial intelligence (AI) can play in informing programmability, using the example of Sail's tailored…
Apr 7, 20252025
Press release · businesswire.com
Apr 2, 20242024
Press release · businesswire
Sail Biomedicines Appoints Clinical and Scientific Leader Dr. Wendy Chung to Its Board
Jan 5, 20242024
Press release · Nasdaq
Sail Biomedicines, Inc., a Flagship Pioneering company and leader in RNA-based programmable medicines, today provided an update on its research funded by the Cystic Fibrosis Foun…
Jan 5, 20242024
Jan 4, 20242024
Sources: the outlets named on each headline, each story once
Milestones
Each milestone is dated by its source: registers, filings, the press
How to cite
Sail Biomedicines, News. Alion, Nov 17, 2026. https://alion.io/company/sail-6/news
